Skip to main content
VITRAFY LIFE SCIENCES LIMITED logo

VITRAFY LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · VFY ISIN · AU0000361297 ASX Professional, scientific and technical activities
Open in API
Filings indexed 91 across all filing types
Latest filing 2025-11-06 Regulatory Filings
Country AU Australia
Listing ASX VFY

About VITRAFY LIFE SCIENCES LIMITED

https://www.vitrafy.com

Vitrafy Life Sciences Limited specializes in the development and commercialization of advanced cryopreservation technologies designed to optimize the preservation and transport of biological materials. The company provides end-to-end cold chain solutions, focusing on maintaining the viability and functionality of sensitive life science products, including cells, tissues, and organs. Its core technology utilizes precise, automated cooling and warming protocols to minimize cellular damage during the freezing process, addressing critical challenges in regenerative medicine, cell and gene therapy, and biobanking. By integrating hardware, software, and specialized consumables, Vitrafy aims to standardize cryopreservation workflows and improve clinical outcomes through enhanced sample recovery and data-driven monitoring throughout the supply chain.

Recent filings

Filing Released Lang Actions
Release of Securities from Mandatory Escrow 1 page
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 7 November 2025 regarding the release of securities from mandatory escrow. It references ASX Listing Rules and details the number of shares being released from escrow and the dates involved. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management commentary. The document is a regulatory announcement about share escrow release, which fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit into more specific categories like Share Issue/Capital Change or Director's Dealing. The document length is short (2186 characters), and it is clearly an announcement rather than a report or detailed filing.
2025-11-06 English
Quarterly Investor Briefing Presentation 13 pages 782.2KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Investor Briefing October 2025' and contains detailed updates on company operations, product development, commercial milestones, board and executive changes, financial updates including cash burn and liquidity, and outlook for the next 9 months. It covers a specific quarter (Q1 FY26) with substantive financial data such as cash costs, net cash burn, and cash balances. The content is comprehensive and focused on a period shorter than a full fiscal year, consistent with a quarterly report. It is not merely an announcement or presentation but includes financial figures and operational analysis. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2025-10-22 English
Q1 FY26 Quarterly Activities Report and Appendix 4C 11 pages 563.4KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 22 October 2025 from Vitrafy Life Sciences Limited presenting its Quarterly Activities Report and Appendix 4C Cash Flow report for the first quarter ended 30 September 2025 of Financial Year 2026. It contains detailed operational updates, financial data including cash flow statements, board and management changes, commercialisation updates, and outlook. The document includes substantive financial data and analysis for a quarter, not just an announcement of a report or a brief summary. It also references the Appendix 4C, which is a quarterly cash flow report required by ASX listing rules, confirming the nature of the report as a quarterly financial report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2025-10-21 English
Vitrafy Q1 FY26 Investor Briefing 1 page 187.2KB
Report Publication Announcement Classification · 95% confidence The document is an ASX announcement dated 20 October 2025 from Vitrafy Life Sciences Limited. It announces the upcoming release of the Quarterly Activities Report and Appendix 4C for the quarter ended 30 September 2025, and an investor briefing scheduled for 23 October 2025. The document itself does not contain the actual quarterly financial data or substantive financial analysis, but rather informs about the future release of the report and the briefing event. The document length is short (2001 characters) and it serves as a notification rather than the report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR).
2025-10-19 English
2025 Notice of Annual General Meeting 38 pages 1.1MB
AGM Information Classification · 100% confidence The document is titled '2025 Notice of Annual General Meeting' and includes details about the upcoming AGM such as date, time, location (hybrid meeting), agenda items including financial statements, resolutions for shareholder voting, proxy forms, and voting restrictions. It is a notice and explanatory statement for the AGM, not the actual annual report or financial statements themselves. The document is an announcement and invitation to shareholders to participate in the AGM and vote on resolutions. It does not contain the full annual report or financial data but references the Annual Report for the year ended 30 June 2025. Therefore, this document fits the category of AGM Information (AGM-R).
2025-10-16 English
Board Renewal 3 pages 242.7KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 16 October 2025 regarding changes in the company's board of directors, including retirements and new appointments. It details the retirement of the Chair and a Non-Executive Director, the appointment of a new Non-Executive Director who will become Chair, and the ongoing board renewal strategy. There is no financial data, earnings information, or report publication mentioned. The content focuses exclusively on board and management changes. Therefore, the document fits the category of Board/Management Information (MANG). The document length (7399 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2025-10-15 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.